Home | Editor's Blog | News | Special Reports | Directory | Events | Advertise | Submit Your News | About Us | Guides News by Zone I News by Date I News by Category   Home News By Zone Medical Engineering Free Newsletter Register for our Free Newsletters Zones Advanced Composites Aerospace Amorphous Metal Structures Analysis and Simulation Asbestos and Substitutes Associations, Research Organisations and Universities Automation Equipment Automotive Biomaterials Building Materials Bulk Handling and Storage CFCs and Substitutes Company Components Consultancy View All Other Carouselweb publications     Medical Engineering Medical optical polymer company adds clean room, single-point diamond turning and advanced metrology Medical Plastics/Polymers : 17 October, 2013 Recent additions to Empire Precision Plastics' facilities aimed at the medical device industry include a new clean room for contract assembly and a full range of optics capabilities. With the addition of Application Engineer Thomas Bittlingmaier, the company completes an expansion of its team and capabilities.   [ View Detail ] Report predicts major growth opportunity in medical polymers Medical Plastics/Polymers : 26 September, 2013 NanoMarkets believes that medical polymers represents a major opportunity in the medical materials market over the next few years. Several factors are leading to growth in this market. Perhaps the most obvious is the ageing of the population in developed nations is expanding the addressable market for polymer implants. Many polymer implants are specifically intended to assist elderly patients.   [ View Detail ] Synthetic bone graft substitute gets CE`approval Osteobiologic Materials : 21 March, 2011 The UK orthobiologics company, Orthos Limited has announced CE approval to market its proprietary βGel synthetic bone graft substitute for use as a bone filler in non-structural areas such as in spinal cages to assist fusion, inside acetabular defects caused by osteolysis and alongside pins and plates to assist bone fracture repair.   [ View Detail ] Materials innovations designed to stimulate tissue regeneration recognised by industry award Medical Implants : 15 January, 2010 A highly competitive award, sponsored by Amgen International, recognises BioCeramic Therapeutics' use of materials innovations to benefit patients with some of the most serious orthopaedic and dental conditions by stimulating and assisting in the body's natural tissue regeneration processes. The materials innovations also have potential future applications in soft tissue regeneration.   [ View Detail ] Funding round in BioCeramic Therapeutics headed by Imperial Innovations Medical Implants : 10 January, 2010 Leading technology commercialisation and investment company Imperial Innovations (AIM: IVO, 'Imperial Innovations'), together with Longbow Capital LLP, has led a funding round for BioCeramic Therapeutics, with a first closing of   [ View Detail ] New chairman succeeds Sir Richard Sykes at BioCeramic Therapeutics Medical Implants : 19 October, 2009 Dr Stephan Rietiker has been appointed chairman of the board of directors of the emerging leader in the field of novel biomaterials for healthcare, BioCeramic Therapeutics (BCT).   [ View Detail ] Elderly patients have a high risk of stroke within six months of a heart attack Medical Implants : 14 April, 2006 Twenty percent of older patients who have suffered a heart attack have a one in 25 chance of being hospitalized for a stroke within six months of discharge from the hospital, according to research at Yale.   [ View Detail ] More patients would refuse treatment if they knew the outcome would mean greatly impaired quality of life Medical Implants : 13 April, 2006 More patients would refuse life-sustaining treatment if they knew the outcome would be a life of severe functional or cognitive impairment, according to a study by a Yale researcher published Thursday in the New England Journal of Medicine.   [ View Detail ] Anti-fungal agent that curbed cocaine use in rodents has opposite effect in humans Medical Implants : 11 April, 2006 Ketoconazole, an anti-fungal agent that helps curb cocaine use in laboratory rats, stimulates rather than reduces cocaine and heroin use in humans, according to a study by researchers at Yale School of Medicine.   [ View Detail ] Yale researchers report on brain activity believed related to sudden infant death syndrome Medical Implants : 08 April, 2006 Neurons thought to play a key role in sudden infant death syndrome are located near some of the largest arteries in the brain, according to a study by a Yale School of Medicine research team published in this week's issue of the journal Nature Neuroscience.   [ View Detail ] Biodegradable polymers in medical applications Medical Implants : 27 March, 2006 Rapra Technology, Europe's leading polymer research and test house, has secured 1.4 Million Euros of EU funding and assembled a consortium that will develop highly innovative supercritical fluid processing technology in order to make advanced multifunctional biodegradable polymer devices.   [ View Detail ] Going the extra mile for specialized heart attack care Medical Implants : 13 March, 2006 Diverting ambulances with patients suffering a heart to a hospital providing emergency angioplasty rather than a closer hospital with no ability to provide this specialized care, may be feasible for the majority of Americans, researchers at Yale School of Medicine and the University of Michigan report in Circulation.   [ View Detail ] Researchers identify gene that protects against kidney stones Medical Implants : 13 March, 2006 New Haven, Conn, Yale School of Medicine researchers report in Nature Genetics this week that they have identified a gene whose function protects the body against kidney stones.   [ View Detail ] Whiplash injury much more severe when head is turned Medical Implants : 13 March, 2006 Persons whose heads are turned at the time of a rear impact collision risk a much more serious whiplash injury with potentially chronic symptoms, and a current Yale School of Medicine study explains why.   [ View Detail ] ADHD medication might also treat hyperactivity symptoms in autism Medical Implants : 22 November, 2005 Methylphenidate, a medication used to treat attention-deficit hyperactivity disorder, may be effective in treating hyperactivity symptoms in children with autism and related pervasive developmental disorders, researchers report in the November Archives of General Psychiatry.   [ View Detail ] Study has implications for vaccine design and autoimmune diseases Medical Implants : 18 November, 2005 A report in Nature November 17 by Yale School of Medicine researchers emphasizes which cells are important in mounting an antibody response to invading microbes.   [ View Detail ] Sleep apnea significantly increases risk for stroke and death Medical Implants : 10 November, 2005 Sleep apnea, a condition where people stop breathing repeatedly while asleep, increases the risk of stroke and death, according to a study from Yale School of Medicine published November 10 in the New England Journal of Medicine.   [ View Detail ] Panel at Yale will examine issues of women and health care Medical Implants : 02 November, 2005 The Women Faculty Forum at Yale and the Yale Office of WorkLife will present a free and public forum on November 16 focusing on women's healthcare from a variety of perspectives.   [ View Detail ] Study clarifies source of lymph node swelling in infections Medical Implants : 25 October, 2005 Contrary to popular belief, lymph nodes swell due to recruitment of lymphocytes that are not specific for any given microbe, according to a report by Yale School of Medicine researchers in this week's Proceedings of the National Academy of Sciences.   [ View Detail ] Cool therapy reduces brain injury and death from oxygen loss in newborns Medical Implants : 13 October, 2005 Infants born with oxygen loss who are given an innovative therapy that lowers their entire body temperature by four degrees within the first six hours of life, have a better chance of survival and lower incidence of brain injury, according to a report in today's issue of The New England Journal of Medicine.   [ View Detail ] Streamlining treatment of heart attack patients Medical Implants : 29 September, 2005 In the first study of its kind, researchers at Yale School of Medicine show how hospitals can streamline procedures to reduce the time they take to treat heart attack patients.   [ View Detail ] Overlapping genetic factors in pathological gambling and major depression Medical Implants : 22 September, 2005 The correlation between pathological gambling and major depression in middle-aged men appears to be heavily influenced by overlapping genetic factors, according to a study by researchers at Yale School of Medicine and Washington University's School of Medicine.   [ View Detail ] Yale procedure cuts recurrence of aggressive uterine cancer Medical Implants : 22 September, 2005 A state-of-the-art treatment program developed at Yale School of Medicine increases survival from the aggressive uterine papillary serous carcinoma and spares some patients the need for additional therapy.   [ View Detail ] Gene that controls the severity of asthma identified Medical Implants : 20 September, 2005 School of Medicine researchers identified a gene prevalent in the population that controls the clinical severity of asthma, according to their report in this week's Proceedings of the National Academy of Sciences.   [ View Detail ] Promising diagnostic tools for multiple sclerosis Medical Implants : 20 September, 2005 Yale School of Medicine researchers, in collaboration with the University of Connecticut Health Center, have identified three rapid diagnostic methods that can target antibodies commonly found in multiple sclerosis patients, greatly improving potential diagnosis and treatment.   [ View Detail ] Aortic aneurysm associated with decreased incidence of atherosclerosis Medical Implants : 19 September, 2005 Oddly enough, having an aneurysm in the ascending aorta is significantly associated with decreased incidence of atherosclerosis, according to a study by Yale School of Medicine researchers published this month in Chest.   [ View Detail ] Eating and body weight regulated by specific neurons Medical Implants : 12 September, 2005 Researchers at Yale School of Medicine provide direct evidence that two parts of a neuronal system, one that promotes eating and another that suppresses eating, are critical for the acute regulation of eating and body weight, according to a study published online in the September 11 issue of Nature Neuroscience.   [ View Detail ] Most embryos produced during IVF do not result in live births Medical Implants : 08 September, 2005 Researchers at Yale School of Medicine have found that 85 percent of embryos transferred during in vitro fertilization fail to become live births, highlighting the need for improving diagnostic techniques to identify viable embryos.   [ View Detail ] Inconsistent effort may be sign of attention disorder in adults and children Medical Implants : 08 September, 2005 The adult or child who only concentrates when performing an activity in which they have a deep interest, such as playing a sport or drawing, may have 'impotence of the mind,' according to a new book by Thomas E. Brown, clinical professor of psychiatry at Yale School of Medicine.   [ View Detail ] Common pesticide may reduce fertility in women Medical Implants : 06 September, 2005 Methoxychlor, a common insect pesticide used on food crops, may interfere with proper development and function of the reproductive tract, leading to reduced fertility in women, researchers at Yale School of Medicine write in the August issue of Endocrinology.   [ View Detail ] GABA halts stem cell production in the brain Medical Implants : 01 September, 2005 Release of the neurotransmitter GABA by adult neuronal precursor cells that develop into neurons limits stem cell proliferation, according to a study at Yale School of Medicine in the September issue of Nature Neuroscience.   [ View Detail ] Studies Find Possible Drug Targets for Improving Vascular Health Medical Implants : 25 August, 2005 The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50, according to a Yale study in the Proceedings of the National Academy of Sciences.   [ View Detail ] Brain distinguishes between nose and mouth odors Medical Implants : 19 August, 2005 Researchers in a study in Neuron this week present the first clear evidence that the brain processes the same odorant molecule differently if it arrives through the nose rather than the mouth.   [ View Detail ] Race and sex disparities in heart attack care, survival not improving Medical Implants : 17 August, 2005 Differences based on race and sex in treatment patterns for hospitalized American heart attack patients have remained unchanged over an eight-year period, despite improvements in quality of heart attack care during this time, Emory and Yale School of Medicine researchers write in the August 18 issue of New England Journal of Medicine.   [ View Detail ] Few changes in antipsychotic prescription seen after diagnosis of diabetes Medical Implants : 09 August, 2005 Among patients being treated with antipsychotic medication, including those who were taking the most generation of drugs, a new diagnoses of diabetes did not result in substantial changes in prescription, according to a a study at Yale School of Medicine.   [ View Detail ] Medication eases obsessive-compulsive symptoms Medical Implants : 29 July, 2005 A medication used to ease symptoms of amyotrophic lateral sclerosis, or Lou Gehrig's disease, also is helpful in treating people with treatment-resistant obsessive-compulsive disorder, according to a pilot study at Yale School of Medicine.   [ View Detail ] Decreased breast cancer survival associated with high TRAIL-R2 expression Medical Implants : 25 July, 2005 High expression of TRAIL-R2, a cell surface receptor that triggers cell death, has been shown to be associated with a decrease in the survival rates of breast cancer patients according to a study published by Yale Cancer Center researchers in Clinical Cancer Research.   [ View Detail ] Clinical trial tests cholesterol drug to minimize multiple sclerosis Medical Implants : 21 July, 2005 Yale School of Medicine is participating in the first clinical trial testing atorvastatin to delay or decrease disease in patients who have experienced a first attack of multiple sclerosis.   [ View Detail ] Early estrogen therapy to prevent heart disease focus of Yale study Medical Implants : 21 July, 2005 Researchers at Yale School of Medicine and seven other national institutions are recruiting patients to participate in the Kronos Early Estrogen Prevention Study to look at the effects of estrogen on heart disease prevention.   [ View Detail ] Understanding and diagnosing an inherited pain syndrome Medical Implants : 12 July, 2005 Yale School of Medicine researchers report the first demonstration that a single mutation in a human sodium channel gene can trigger pain in people with an inherited pain syndrome known as primary erythromelalgia, according to a study published this month in the journal Brain.   [ View Detail ] Protein amplification in melanoma is possible drug target Medical Implants : 11 July, 2005 Researchers have pinpointed specific gene and protein over-production in metastatic melanoma, pointing the way to a possible new drug target, according to a study published in Nature July 7.   [ View Detail ] Groundbreaking study helps explain why preemie brains improve over time Medical Implants : 27 June, 2005 Infants born prematurely and with hypoxia, inadequate oxygen to the blood, are able to recover some cells, volume and weight in the brain after oxygen supply is restored, Yale School of Medicine researchers report in Experimental Neurology.   [ View Detail ] Nicotine helps Schizophrenics with attention and memory Medical Implants : 23 June, 2005 Cigarette smoking may improve attention and short   [ View Detail ] Breast cancer growth regulator holds promise for more targeted treatment Medical Implants : 22 June, 2005 Researchers at Yale School of Medicine have discovered the breast cancer growth regulator sEGFR, which may be a useful tool in monitoring a patient's responsiveness to treatment with the drug letrozole.   [ View Detail ] Yale scientists find MicroRNA regulates ras cancer gene Medical Implants : 17 March, 2005 Research in the laboratory of Assistant Professor Frank J. Slack at Yale University has identified a new way that a familiar gene is regulated in lung cancer, presenting new possibilities for diagnosis and treatment. The work is reported in March issues of the journals Cell and Developmental Cell.   [ View Detail ] Boosting HIV screening can increase survival and is cost effective Medical Implants : 09 February, 2005 Expanded HIV screening can increase patient life span, prevent the spread of the disease, and is cost effective, researchers at Yale, Harvard and the Massachusetts General Hospital report in the February 10 issue of the New England Journal of Medicine.   [ View Detail ] Varicella vaccine effective on chicken pox Medical Implants : 03 February, 2005 The varicella vaccine is almost 90 percent effective against chickenpox, but its impact on herpes zoster (shingles) is unknown and needs wider surveillance, Yale School of Medicine researchers write in today's New England Journal of Medicine perspective section.   [ View Detail ] Premature births from inflammation and infection rapidly detected by proteomics technology Medical Implants : 26 January, 2005 A combination of four proteins that result from inflammation and infection and lead to premature birth can be rapidly and accurately detected in the amniotic fluid of pregnant women using proteomics technology, Yale researchers report in two studies in the February issue of British Journal of Obstetrics and Gynecology   [ View Detail ] Blocking molecule protects health of implants Medical Implants : 20 December, 2004 Blocking a key molecule protects breast implants, permanent catheters, pacemakers, artificial joints, glucose sensors for diabetics, and other biomaterials from rejection and damage by the body, according to a study published this month in The American Journal of Pathology.   [ View Detail ] World's first medical grade 17' terminal for graphics-intensive applications Medical Implants : 09 April, 2004 Aimed at the market for graphics-intensive medical applications, POC-174 is based on the Mobile Intel Pentium 4 Processor-M, and is UL60601-1, EN60601 certified. POC-174's TFT LCD screen has a wide viewing angle of 170 degrees, which combined with high contrast ratio, high brightness and resolution, makes it the Point-of-care terminal of choice for applicationssuch as CT diagnosis, X-rays, PACS and DICOM.   [ View Detail ] First | Prev  | 1 | 2 | 3 | 4  | Next  | Last

Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides      © 2012 NewMaterials.com